Shanghai Pharmaceuticals Holding Co., Ltd SHPMY Stock
Shanghai Pharmaceuticals Holding Co., Ltd Price Chart
Shanghai Pharmaceuticals Holding Co., Ltd SHPMY Financial and Trading Overview
Contents
- Shanghai Pharmaceuticals Holding Co., Ltd Price Chart
- Shanghai Pharmaceuticals Holding Co., Ltd SHPMY Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shanghai Pharmaceuticals Holding Co., Ltd
- Q&A For Shanghai Pharmaceuticals Holding Co., Ltd Stock
Shanghai Pharmaceuticals Holding Co., Ltd stock price | 6.83 USD |
Previous Close | 9.65 USD |
Open | 9.65 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 9.65 - 9.65 USD |
52 Week Range | 6.42 - 10.47 USD |
Volume | 31 USD |
Avg. Volume | 566 USD |
Market Cap | 10.2B USD |
Beta (5Y Monthly) | 0.320547 |
PE Ratio (TTM) | 8.539823 |
EPS (TTM) | 0.84 USD |
Forward Dividend & Yield | 0.31 (3.25%) |
Ex-Dividend Date | July 21, 2022 |
1y Target Est | N/A |
SHPMY Valuation Measures
Enterprise Value | 31B USD |
Trailing P/E | 8.539823 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.04228356 |
Price/Book (mrq) | 0.104104854 |
Enterprise Value/Revenue | 0.128 |
Enterprise Value/EBITDA | 3.114 |
Trading Information
Shanghai Pharmaceuticals Holding Co., Ltd Stock Price History
Beta (5Y Monthly) | 0.320547 |
52-Week Change | 19.15% |
S&P500 52-Week Change | 20.43% |
52 Week High | 10.47 USD |
52 Week Low | 6.42 USD |
50-Day Moving Average | 9.94 USD |
200-Day Moving Average | 8.6 USD |
SHPMY Share Statistics
Avg. Volume (3 month) | 566 USD |
Avg. Daily Volume (10-Days) | 2.19K USD |
Shares Outstanding | 740.56M |
Float | 327.46M |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.61 |
Trailing Annual Dividend Yield | 6.32% |
5 Year Average Dividend Yield | 337.00% |
Payout Ratio | 0.2682 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 2.43% |
Operating Margin (ttm) | 3.57% |
Gross Margin | 13.12% |
EBITDA Margin | 4.12% |
Management Effectiveness
Return on Assets (ttm) | 2.78% |
Return on Equity (ttm) | 9.61% |
Income Statement
Revenue (ttm) | 241.31B USD |
Revenue Per Share (ttm) | 326.33 USD |
Quarterly Revenue Growth (yoy) | 16.40% |
Gross Profit (ttm) | N/A |
EBITDA | 9.96B USD |
Net Income Avi to Common (ttm) | 5.88B USD |
Diluted EPS (ttm) | 1.13 |
Quarterly Earnings Growth (yoy) | 21.30% |
Balance Sheet
Total Cash (mrq) | 38.11B USD |
Total Cash Per Share (mrq) | 51.52 USD |
Total Debt (mrq) | 50.66B USD |
Total Debt/Equity (mrq) | 63.42 USD |
Current Ratio (mrq) | 1.375 |
Book Value Per Share (mrq) | 92.695 |
Cash Flow Statement
Operating Cash Flow (ttm) | 4.61B USD |
Levered Free Cash Flow (ttm) | -1122903680 USD |
Profile of Shanghai Pharmaceuticals Holding Co., Ltd
Country | United States |
State | N/A |
City | Shanghai |
Address | Shanghai Pharmaceutical Building |
ZIP | 200020 |
Phone | 86 21 6373 0908 |
Website | https://www.sphchina.com |
Industry | Medical Distribution |
Sector(s) | Healthcare |
Full Time Employees | 47877 |
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Q&A For Shanghai Pharmaceuticals Holding Co., Ltd Stock
What is a current SHPMY stock price?
Shanghai Pharmaceuticals Holding Co., Ltd SHPMY stock price today per share is 6.83 USD.
How to purchase Shanghai Pharmaceuticals Holding Co., Ltd stock?
You can buy SHPMY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shanghai Pharmaceuticals Holding Co., Ltd?
The stock symbol or ticker of Shanghai Pharmaceuticals Holding Co., Ltd is SHPMY.
Which industry does the Shanghai Pharmaceuticals Holding Co., Ltd company belong to?
The Shanghai Pharmaceuticals Holding Co., Ltd industry is Medical Distribution.
How many shares does Shanghai Pharmaceuticals Holding Co., Ltd have in circulation?
The max supply of Shanghai Pharmaceuticals Holding Co., Ltd shares is 1.21B.
What is Shanghai Pharmaceuticals Holding Co., Ltd Price to Earnings Ratio (PE Ratio)?
Shanghai Pharmaceuticals Holding Co., Ltd PE Ratio is 8.13095300 now.
What was Shanghai Pharmaceuticals Holding Co., Ltd earnings per share over the trailing 12 months (TTM)?
Shanghai Pharmaceuticals Holding Co., Ltd EPS is 0.84 USD over the trailing 12 months.
Which sector does the Shanghai Pharmaceuticals Holding Co., Ltd company belong to?
The Shanghai Pharmaceuticals Holding Co., Ltd sector is Healthcare.